Toxicological evaluation of a fish oil concentrate containing Very Long Chain Fatty Acids
Food and Chemical Toxicology · 2024
DOI: 10.1016/j.fct.2024.114518 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2024. Verfasst von Derek Tobin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Epax Norway AS, Norway. Electronic address: derek.tobin@pelagia.com. Hauptthemen laut MEDLINE: Fish Oils, Fatty Acids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norges forskningsråd.
Abstract (Originalsprache)
Very long chain fatty acids (VLCFA) have a chain length ≥24 carbons. Fish contain low levels of these fatty acids. A commercial oil called EPAX® Evolve 05 with an up-concentration of VLCFAs of approximately 10 times, has been developed as a dietary supplement by Epax Norway AS. A series of toxicological studies were performed using mice and rats to determine the safety and toxicity of repeat dosing with a gavage administered VLCFA formulation. The results suggest transient lipid accumulation in kidneys and liver. Lipid accumulation was seen with the test item and with the soya control but was not dose related. Liver and kidney lipid accumulation, whilst present in 14- day repeat dose study, was absent in a 90-day rat study. No treatment-effect was seen in urine analysis in any of the studies. No treatment-related effects were seen with a functional observation battery, ophthalmological examination, haematology, urine analysis, oestrus cycle, thyroid hormones, organ weight, or histopathology. In the 90-day study the liver enzymes ALP, AST and ALT were statistically significantly increased with test item but within control values. There were no associated histological findings in the liver suggesting there was no toxic effect and the normalisation of values for all liver enzymes in the recovery groups suggests an adaptive response rather than a prevailing toxic response. The no-observed-adverse-effect level (NOAEL) was determined as 1200 mg VLCFA/kg b.w./day.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epax Norway AS, Norway. Electronic address: derek.tobin@pelagia.com.
- Epax Norway AS, Norway.
- Vedic Lifesciences, India.
- NOFIMA, Norway.
- Dornish Consulting, Norway.
Förderung
- Norges forskningsråd
Zitieren
APA
Tobin, D., Svensen, H., Shanmugasundaram, D., Ruyter, B., Stoknes, I., & Dornish, M. (2024). Toxicological evaluation of a fish oil concentrate containing Very Long Chain Fatty Acids. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2024.114518
Vancouver
Tobin D, Svensen H, Shanmugasundaram D, Ruyter B, Stoknes I, Dornish M. Toxicological evaluation of a fish oil concentrate containing Very Long Chain Fatty Acids. Food and Chemical Toxicology. 2024. doi:10.1016/j.fct.2024.114518
BibTeX
@article{Tobin2024,
author = {Tobin, Derek and Svensen, Harald and Shanmugasundaram, Devanand and Ruyter, Bente and Stoknes, Iren and Dornish, Michael},
title = {Toxicological evaluation of a fish oil concentrate containing Very Long Chain Fatty Acids},
journal = {Food and Chemical Toxicology},
year = {2024},
doi = {10.1016/j.fct.2024.114518}
}
EUVIMED